Ligand validation:5IWL

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 5IWL designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5IWL_NAG_D_202	37%	79%	0.115	0.808	0.35	0.51	-	-	1	0	100%	0.9333
5IWL_NAG_C_201	34%	79%	0.119	0.802	0.34	0.51	-	-	2	0	100%	0.9333
5IWL_NAG_D_201	28%	77%	0.124	0.776	0.45	0.47	-	-	0	0	100%	0.9333
5IWL_NAG_D_203	12%	88%	0.143	0.664	0.26	0.4	-	-	0	0	100%	0.9333
5IWL_NAG_C_203	10%	85%	0.137	0.635	0.38	0.36	-	-	0	0	100%	0.9333
5IWL_NAG_C_202	4%	75%	0.162	0.53	0.51	0.46	-	-	0	0	100%	0.9333
2JJS_NAG_B_1120	94%	56%	0.075	0.972	0.61	1.06	-	1	0	0	100%	0.9333
4CMM_NAG_B_1121	87%	72%	0.079	0.951	0.29	0.78	-	1	1	0	100%	0.9333
2VSC_NAG_C_1116	81%	38%	0.092	0.943	0.58	1.82	-	5	0	0	100%	0.9333
2JJT_NAG_D_1116	80%	46%	0.103	0.952	0.68	1.38	-	1	3	0	100%	0.9333
5TZ2_NAG_C_203	59%	90%	0.125	0.906	0.22	0.38	-	-	0	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3GXM_NAG_A_498	100%	45%	0.026	0.992	0.75	1.34	-	2	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.